Dianne Gelien Bouwknegt

6PUBLICATIONS
52CO-AUTHORS
Predictive and prognostic markersRespiratory diseasesNanotoxicology, health and safetyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 03, 2026
Evolving patient journey in the management of active perianal fistulizing Crohn's disease: A temporal perspective.

|Apr 04, 2026
Prospective real-world experience with risankizumab in difficult-to-treat Crohn's disease: results from the Dutch Initiative on Crohn and Colitis Registry.

Loriane M M Verleye, Marieke J Pierik, Annemarie C de Vries

|Mar 18, 2026
The decline of 6-thioguanine nucleotides is not linked to impaired efficacy or safety of thiopurines in pregnant women with inflammatory bowel disease.

Dianne G Bouwknegt, Paola Mian, Femke Groen

|Dec 05, 2025
Filgotinib Is an Effective and Safe Treatment Option for Difficult-To-Treat Ulcerative Colitis: Real-World Evidence of the Dutch Initiative on Crohn and Colitis (ICC) Registry.

M R Naber, A E van der Meulen, P W Voorneveld

|Jun 04, 2025
Gene-Environment Interactions in Inflammatory Bowel Disease: A Systematic Review of Human Epidemiologic Studies.

Jingjing Bai, Dianne Gelien Bouwknegt, Rinse Karel Weersma

|Jan 05, 2025
Pregnancy With a Stoma is Feasible, Though Associated With Manageable Complications.

Dianne Gelien Bouwknegt, Albertina Henrika Chantall van der Weide, Gerard Dijkstra

Pageof 1

Frequent Collaborators

4 joint publications

Marijn Caroline Visschedijk

3 joint publications

Marjolijn Duijvestein

3 joint publications

Fiona D M van Schaik

2 joint publications

Myrthe R Naber